Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Mem. Inst. Oswaldo Cruz ; 110(8): 1042-1050, Dec. 2015. graf
Artigo em Inglês | LILACS | ID: lil-769830

RESUMO

The existence of the nervous form of Chagas disease is a matter of discussion since Carlos Chagas described neurological disorders, learning and behavioural alterations in Trypanosoma cruzi-infected individuals. In most patients, the clinical manifestations of the acute phase, including neurological abnormalities, resolve spontaneously without apparent consequence in the chronic phase of infection. However, chronic Chagas disease patients have behavioural changes such as psychomotor alterations, attention and memory deficits, and depression. In the present study, we tested whether or not behavioural alterations are reproducible in experimental models. We show that C57BL/6 mice chronically infected with the Colombian strain of T. cruzi (150 days post-infection) exhibit behavioural changes as (i) depression in the tail suspension and forced swim tests, (ii) anxiety analysed by elevated plus maze and open field test sand and (iii) motor coordination in the rotarod test. These alterations are neither associated with neuromuscular disorders assessed by the grip strength test nor with sickness behaviour analysed by temperature variation sand weight loss. Therefore, chronically T. cruzi-infected mice replicate behavioural alterations (depression and anxiety) detected in Chagas disease patients opening an opportunity to study the interconnection and the physiopathology of these two biological processes in an infectious scenario.


Assuntos
Animais , Feminino , Ansiedade/parasitologia , Doença de Chagas/complicações , Depressão/parasitologia , Comportamento de Doença , Atividade Motora , Trypanosoma cruzi , Escala de Avaliação Comportamental , Doença Crônica , Sistema Nervoso Central/parasitologia , Modelos Animais de Doenças , Elevação dos Membros Posteriores , Força Muscular/fisiologia , Esforço Físico , Parasitemia/mortalidade , Equilíbrio Postural/fisiologia , Desempenho Psicomotor/fisiologia , Natação
2.
Am J Alzheimers Dis Other Demen ; 29(3): 205-14, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24413543

RESUMO

Toxoplasma gondii is an intracellular protozoan infecting 30% to 50% of global human population. Recently, it was suggested that chronic latent neuroinflammation caused by the parasite may be responsible for the development of several neurodegenerative diseases manifesting with the loss of smell. Studies in animals inoculated with the parasite revealed cysts in various regions of the brain, including olfactory bulb. Development of behavioral changes was paralleled by the preferential persistence of cysts in defined anatomic structures of the brain, depending on the host, strain of the parasite, its virulence, and route of inoculation. Olfactory dysfunction reported in Alzheimer's disease, multiple sclerosis, and schizophrenia was frequently associated with the significantly increased serum anti-T gondii immunoglobulin G antibody levels. Damage of the olfactory system may be also at least in part responsible for the development of depression because T gondii infection worsened mood in such patients, and the olfactory bulbectomized rat serves as a model of depression.


Assuntos
Doenças Autoimunes do Sistema Nervoso/etiologia , Depressão/etiologia , Doenças Neurodegenerativas/etiologia , Transtornos do Olfato/etiologia , Toxoplasmose/complicações , Animais , Doenças Autoimunes do Sistema Nervoso/imunologia , Doenças Autoimunes do Sistema Nervoso/parasitologia , Depressão/imunologia , Depressão/parasitologia , Humanos , Doenças Neurodegenerativas/imunologia , Doenças Neurodegenerativas/parasitologia , Transtornos do Olfato/imunologia , Transtornos do Olfato/parasitologia , Toxoplasmose/imunologia , Toxoplasmose/parasitologia
3.
Neuroimmunomodulation ; 16(2): 122-33, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19212132

RESUMO

Toxoplasma gondii infects approximately 30% of the world's population, but causes overt clinical symptoms in only a small proportion of people. In recent years, the ability of the parasite to manipulate the behaviour of infected mice and rats and alter personality attributes of humans has been reported. Furthermore, a number of studies have now suggested T. gondii infection as a risk factor for the development of schizophrenia and depression in humans. As T. gondii forms cysts that are located in various anatomical sites including the brain during a chronic infection, it is well placed anatomically to mediate these effects directly. The T. gondii genome is known to contain 2 aromatic amino acid hydroxylases that potentially could directly affect dopamine and/or serotonin biosynthesis. However, stimulation of the immune response has also recently been associated with mood and behavioural alterations in humans, and compounds designed to alter mood, such as fluoxetine, have been demonstrated to alter aspects of immune function. Herein, the evidence for T.-gondii-induced behavioural changes relevant to schizophrenia and depression is reviewed. Potential mechanisms responsible for these changes in behaviour including the role of tryptophan metabolism and the hypothalamic-pituitary-adrenal axis are discussed.


Assuntos
Transtornos Mentais/etiologia , Doenças do Sistema Nervoso/etiologia , Toxoplasmose/psicologia , Animais , Comportamento , Comportamento Animal , Gatos , Citocinas/fisiologia , Depressão/epidemiologia , Depressão/etiologia , Depressão/parasitologia , Dopamina/metabolismo , Feminino , Interações Hospedeiro-Parasita , Humanos , Masculino , Transtornos Mentais/epidemiologia , Transtornos Mentais/parasitologia , Transtornos Mentais/fisiopatologia , Camundongos , Doenças do Sistema Nervoso/epidemiologia , Doenças do Sistema Nervoso/parasitologia , Doenças do Sistema Nervoso/fisiopatologia , Neurônios/parasitologia , Sistemas Neurossecretores/fisiopatologia , Proteínas de Protozoários/fisiologia , Ratos , Fatores de Risco , Esquizofrenia/epidemiologia , Esquizofrenia/etiologia , Esquizofrenia/parasitologia , Serotonina/metabolismo , Toxoplasma/enzimologia , Toxoplasma/crescimento & desenvolvimento , Toxoplasma/fisiologia , Toxoplasmose/epidemiologia , Toxoplasmose/imunologia , Toxoplasmose/fisiopatologia , Toxoplasmose Animal/epidemiologia , Toxoplasmose Animal/imunologia , Toxoplasmose Animal/parasitologia , Toxoplasmose Animal/fisiopatologia , Triptofano/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA